ARCHIVES

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

NI Selects15 Cancer Patient Advocates for Director’s Consumer Liaison Group

November 23, 1997

Rosenberg’s Gene Transfer Protocol Approved By NIH Advisory Group

October 7, 1988

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

Reaction: Voices Of Believers Drown Out Skeptics

November 20, 2009

In Brief: ACS Begins Narrowing List of Job Applicants; IL-2 Gets BRM Ok; Pitot Resigns McArdle Post

January 31, 1992